Search -

Displaying 61 - 73 of 73

Sort: Relevancy | Date

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Orsiro

Presenter: Pieter C. Smits, Philip M. Urban, Thomas Pilgrim

October 12, 2015

News Industry News

Biotronik launches China arm in Orsiro stent trial

August 31, 2015

Presentation TCT 2014

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Presenter: Rafael Ruiz-Salmeron

September 16, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

Presentation TCT 2013

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Presenter: Thierry Lefevre

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Partner Content

Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence

March 7, 2019

CME

Advertisement

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Device and Clinical Program Highlights: Orsiro

Biotronik launches China arm in Orsiro stent trial

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Orsiro (BIOTRONIK) Program Update

Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content